Novartis loses patent battle in SC over cancer drug
Monday, April 1st, 2013New Delhi: In a landmark verdict with far reaching consequences, the Supreme Court on Monday rejected a plea by Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India, thereby paving way for the continued production of the drug’s generic version by Indian companies. Glivec, used in treating chronic myeloid […]